Diagnosis & Testing

DHT and Hair Loss: Complete Explanation

2,901 words·Compiled from cited medical literature·Not medical advice

Understanding Why DHT Causes Hair Loss—And What You Can Do About It

Who This Is For#

This guide is for you if:

• You want to understand why hair loss happens at the hormonal level
• You've heard about DHT but want the science explained clearly
• You're considering finasteride or dutasteride and want to understand how they work
• You're interested in natural DHT-blocking alternatives
• You want to understand the genetic component of pattern hair loss

This guide is NOT for you if:

• You're experiencing sudden hair loss (may not be DHT-related)
• You have hair loss with scalp symptoms like pain, redness, or scarring
• You need immediate treatment decisions (consult a dermatologist)
• You're female (DHT works differently; see our women's hair loss guide)
• You haven't been diagnosed with pattern hair loss

What Is DHT?#

DHT stands for dihydrotestosterone. It's an androgen hormone—a chemical messenger that drives masculine characteristics. But unlike what the name might suggest, DHT isn't foreign or harmful. Your body makes it deliberately.

Here's the basic process: Your body produces testosterone. An enzyme called 5-alpha reductase converts some of that testosterone into DHT. This happens in various tissues including your prostate, skin, and—importantly for our discussion—your scalp.

DHT is approximately 10 times more potent than testosterone and has 2-5 times higher affinity for androgen receptors. This increased potency explains why DHT drives biological processes that testosterone cannot accomplish alone—and why it has such powerful effects on susceptible hair follicles. The conversion happens locally in tissues, meaning your scalp makes its own DHT from circulating testosterone.

The 5-Alpha Reductase Enzyme#

The enzyme that creates DHT exists in two main forms, called isoenzymes:

Type 1 5-alpha reductase (encoded by the SRD5A1 gene on chromosome 5):

• Found primarily in sebaceous glands (oil glands) in scalp skin
• Lower concentration in hair follicles themselves
• May contribute to scalp oiliness

Type 2 5-alpha reductase (encoded by the SRD5A2 gene on chromosome 2):

• Found in hair follicles of the scalp
• Higher concentration in frontal and vertex (crown) regions
• Primary driver of follicular DHT production

The critical evidence for Type 2's role comes from genetic studies: men born with Type 2 5-alpha reductase deficiency do not develop male pattern hair loss. Their bodies cannot produce DHT in hair follicles, so regardless of their testosterone levels, their scalp hair remains intact. This discovery led directly to the development of finasteride, which specifically targets Type 2 5-alpha reductase.

How DHT Causes Hair Loss#

Understanding the miniaturization process helps explain why early treatment matters:

Step 1: DHT Binds to Androgen Receptors Hair follicles in certain scalp areas (frontal hairline, temples, crown) contain androgen receptors in their dermal papilla cells—the "command center" of each follicle. When DHT binds to these receptors, it triggers a cascade of genetic changes.

Step 2: Gene Expression Changes The DHT-receptor complex enters the cell nucleus and activates specific genes. These genes produce proteins that progressively alter the hair follicle's behavior.

Step 3: Growth Cycle Disruption The anagen (growth) phase shortens while the telogen (resting) phase lengthens. Each successive hair cycle produces a thinner, shorter hair.

Step 4: Follicular Miniaturization Over multiple cycles, terminal hairs (thick, pigmented) transform into vellus hairs (thin, unpigmented, barely visible). The follicle itself shrinks.

DHT also suppresses the Wnt/β-catenin signaling pathway, which is essential for hair follicle proliferation and maintenance. Additionally, DHT-activated follicles release transforming growth factor beta (TGF-β), which further accelerates miniaturization. This explains why blocking DHT early can halt progression—once the follicle shrinks, reversing miniaturization becomes increasingly difficult.

The Androgen Paradox#

One puzzling aspect of DHT is its opposite effects on different hair:

Hair DHT Stimulates:

• Beard and facial hair
• Chest hair
• Pubic hair
• Underarm hair

Hair DHT Miniaturizes:

• Frontal hairline
• Temples
• Vertex (crown)

This "androgen paradox" occurs because hair follicles in different body regions have different genetic programming. Scalp follicles in susceptible areas are genetically programmed to respond negatively to DHT, while facial and body follicles respond positively. This is why men can have full beards while losing scalp hair—same hormone, opposite responses based on follicle genetics.

Genetic Sensitivity: The AR Gene#

DHT doesn't cause hair loss in everyone. The determining factor is genetic sensitivity, and the androgen receptor (AR) gene is the most important genetic player.

Key Facts About the AR Gene:

• Located on the X chromosome at position Xq11-q12
• Contains variable repeat regions (CAG and GGN repeats) that affect receptor sensitivity
• Accounts for approximately 40% of the genetic risk for pattern hair loss (etiological fraction of 0.46)
• Variations increase androgen receptor sensitivity in scalp follicles

Because the AR gene is on the X chromosome, and men inherit their X from their mother, the maternal inheritance pattern is significant. Research shows the average phenotypic resemblance is greater between affected males and their maternal grandfathers than between affected males and their fathers. However, hair loss is polygenic—multiple genes contribute—so looking at both sides of the family provides a more complete picture.

This genetic sensitivity explains why two men with identical DHT levels can have vastly different hair: one's receptors respond more strongly to DHT than the other's.

Does Serum DHT Level Matter?#

You might assume that high DHT levels cause hair loss and low levels protect against it. Reality is more nuanced.

What Research Shows:

• Studies found increased serum DHT in some AGA patients but also in controls
• Differences in mean DHT values were not statistically significant between groups
• Visual examination is more diagnostic than serum DHT testing
• Local scalp DHT matters more than circulating levels

Your serum DHT level is less important than two other factors: (1) how much DHT your scalp produces locally via 5-alpha reductase, and (2) how sensitive your follicles' androgen receptors are. A man with "normal" DHT levels but highly sensitive receptors may lose more hair than a man with elevated DHT and less sensitive receptors. This is why DHT blood tests have limited diagnostic value for hair loss—the action happens locally, not systemically.

Pharmaceutical DHT Blockers#

Two FDA-approved medications reduce DHT levels through 5-alpha reductase inhibition:

Finasteride (Propecia)#

Mechanism: Selectively inhibits Type 2 and Type 3 5-alpha reductase DHT Reduction:

• Serum: ~70% reduction
• Scalp: 64-69% reduction
• Prostate: ~90% reduction

Timeline:

• 24 hours: 65% reduction in serum DHT
• Months 1-3: DHT stabilization, possible temporary shedding
• Months 3-6: Visible reduction in hair loss, early regrowth
• Month 12: Optimal results typically apparent
• Month 24: Continued improvement in some men

Efficacy Data:

• 86% maintain or increase hair count at 1 year
• 48% show improvement at 1 year
• 66% show improvement at 2 years
• 99.1% showed increased hair growth over 10 years in one study of 532 men

Finasteride doesn't achieve 100% DHT reduction, which is actually beneficial—some DHT serves normal physiological functions. The 70% reduction is sufficient to slow or stop miniaturization in most men while maintaining DHT for other tissues. Finasteride only works while you're taking it; DHT returns to normal within 14 days of stopping, and hair loss resumes within 6-12 months.

Dutasteride (Avodart)#

Mechanism: Inhibits all three 5-alpha reductase isoenzymes (Types 1, 2, and 3) DHT Reduction:

• Serum: 92-94.7% reduction
• Scalp: 51% reduction

Comparative Data: In a 416-man randomized trial over 24 weeks, dutasteride 2.5 mg was superior to finasteride 5 mg for hair count increase. Dutasteride provides approximately 3x stronger Type 2 inhibition and 100x stronger Type 1 inhibition than finasteride.

Despite greater systemic DHT suppression, dutasteride only reduces scalp DHT by 51% compared to finasteride's 64-69%. This paradox suggests that scalp DHT levels don't perfectly correlate with hair outcomes—other factors including receptor sensitivity and local tissue responses matter. Dutasteride is FDA-approved for hair loss only in Japan and South Korea due to concerns about increased adverse effects from more complete DHT suppression.

Natural DHT Blocking Options#

For those preferring non-pharmaceutical approaches, several natural compounds show evidence of DHT-blocking activity:

Saw Palmetto (Serenoa repens)#

Mechanism: Competitive, nonselective inhibitor of both 5-alpha reductase isoforms; blocks nuclear uptake of DHT; decreases DHT binding to androgen receptors by nearly 50%

Clinical Evidence:

• 60% improvement in overall hair quality
• 27% improvement in total hair count
• 83.3% of patients showed increased hair density
• 38% showed increased hair growth over 24 months (320 mg daily)

DHT Reduction: 15-20% (compared to 60-70% with finasteride)

Dosage: 320 mg daily appears safe and effective; higher doses haven't shown additional benefit

Pumpkin Seed Oil#

Mechanism: Contains phytosterols that inhibit testosterone-to-DHT conversion

Clinical Evidence:

• Randomized, double-blind, placebo-controlled trial of 76 men
• 24 weeks of treatment
• Treatment group: 40% increase in mean hair count
• Placebo group: 10% increase
• Statistically significant difference

Dosage: 400 mg daily (dosages of 400-1000 mg appear safe)

Natural DHT blockers offer a gentler approach with minimal side effects. However, their DHT reduction is substantially less than pharmaceutical options—saw palmetto's 15-20% reduction versus finasteride's 70%. A small Korean trial found additive benefits when combining 320 mg saw palmetto with 1000 mg pumpkin seed oil, raising success rates to 68%. Natural options may work best for early-stage hair loss or as adjuncts to pharmaceutical treatment.

Timeline Expectations#

Understanding realistic timelines prevents discouragement:

Initial Phase (Month 1)

• DHT levels dropping rapidly
• No visible changes expected
• Follicles beginning to respond internally

Adjustment Phase (Months 1-3)

• Possible temporary shedding (paradoxical but positive sign)
• Weakened hairs being replaced
• Stabilization of hair loss rate

Early Results Phase (Months 3-6)

• Reduced daily shedding noticeable
• Some early regrowth visible
• Hair texture may improve

Optimal Results Phase (Months 6-12)

• Maximum regrowth typically achieved
• Hair density improvements visible
• Pattern stabilization

Maintenance Phase (Year 2+)

• Some men continue improving through year 2
• Long-term maintenance of results
• Periodic assessment recommended

The 3-6 month timeline for visible results reflects hair biology, not medication failure. Hair follicles must cycle through complete growth phases to produce new, healthier hairs. Early shedding often indicates the treatment is working—miniaturized hairs are being pushed out by stronger follicles. Patience through the first 6-12 months is essential for accurate efficacy assessment.

Should You Test Your DHT Levels?#

DHT testing is available but has limitations for hair loss diagnosis:

When Testing May Be Useful:

• Monitoring response to 5-alpha reductase inhibitor treatment
• Evaluating testosterone-to-DHT ratio
• Investigating other androgen-related symptoms
• Research or detailed personal tracking

When Testing Has Limited Value:

• Diagnosing pattern hair loss (visual examination more reliable)
• Predicting response to treatment
• Comparing to "normal" ranges (high local sensitivity can cause hair loss with normal systemic levels)

More Informative Tests: If evaluating hormonal factors, a complete panel including free testosterone, total testosterone, DHEA, androstenedione, SHBG, and potentially thyroid function provides more actionable information.

Dermatologists rarely order DHT levels specifically for hair loss diagnosis. The clinical presentation—characteristic pattern, gradual onset, family history—combined with physical examination and trichoscopy provides more diagnostic value than blood tests. DHT testing is most useful for research purposes or tracking treatment response rather than initial diagnosis.

Combining Approaches#

Many men achieve optimal results through strategic combination:

Common Effective Combinations:

• Finasteride (systemic DHT reduction) + Minoxidil (topical growth stimulation)
• Finasteride + Ketoconazole shampoo (mild topical anti-androgen)
• Low-dose finasteride + saw palmetto + pumpkin seed oil
• Natural blockers + microneedling + topical treatments

Because hair loss involves multiple mechanisms beyond DHT alone (inflammation, scalp blood flow, follicle health), combination approaches targeting different pathways often outperform single treatments. However, combining multiple pharmaceutical DHT blockers (like finasteride and dutasteride) is not recommended due to redundant mechanisms and increased side effect risk.

The Bottom Line#

DHT is the primary driver of pattern hair loss in genetically susceptible individuals. Key points to remember:

1. DHT itself isn't the enemy—genetic sensitivity is. Your androgen receptors determine how your follicles respond to DHT.

1. The AR gene on the X chromosome contributes approximately 40% of genetic risk, explaining the maternal inheritance pattern often observed.

1. Serum DHT levels are less important than local production and receptor sensitivity. Don't assume high DHT means more hair loss or low DHT means protection.

1. Finasteride reduces DHT by ~70% at the scalp level, which is sufficient for most men to slow or stop progression.

1. Natural options like saw palmetto and pumpkin seed oil offer gentler DHT reduction (15-20%) suitable for early-stage loss or combination therapy.

1. Results take 3-12 months to become visible. Early shedding often indicates treatment is working.

1. Treatment must continue to maintain results. DHT returns to normal within 14 days of stopping finasteride.

Frequently Asked Questions#